Open AccessJournal Article
Pulmonary artery thrombosis in three dogs with hyperadrenocorticism.
62
TL;DR: It was concluded that pulmonary artery thrombosis should be suspected in cases of intractable dyspnea, right-sided heart failure of unexplained origin, and acute unexplainable death.
read more
Abstract: Varying degrees of respiratory distress developed in 3 dogs in which hyperadrenocorticism was diagnosed The respiratory distress was attributed to pulmonary artery thrombosis Radiography revealed pleural effusion, increased diameter and blunting of the pulmonary arteries, lack of perfusion of the obstructed pulmonary vasculature, and overperfusion of the unobstructed pulmonary vasculature Thrombosis was confirmed by nonselective angiocardiography in each case In 1 case, selective angiocardiography showed marked reduction of the transit time of contrast medium from the right atrium to the aorta Hypertension proximal to the site of thrombosis was confirmed in 2 cases by showing increases in the right ventricular systolic pressures (80 mm of Hg in one case and 54 mm of Hg in the other case) In 3 cases, there was moderate hypoxemia with hypocapnia, suggesting a ventilation-perfusion mismatch Clinical findings other than respiratory distress included hepatomegaly, ventral edema, orthopnea, and a jugular pulse Pulmonary artery thrombosis, as it occurred in these 3 cases, was compared with the disease in man It was concluded that pulmonary artery thrombosis should be suspected in cases of intractable dyspnea, right-sided heart failure of unexplained origin, and acute unexplainable death
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Diagnosis of spontaneous canine hyperadrenocorticism: 2012 ACVIM consensus statement (small animal).
TL;DR: The Panel believes that references ranges should be reestablished and the role of cortisol precursors and sex hormones in causing a syndrome of occult hyperadrenocorticism remains unclear.
230
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs
Carol R. Reinero,Lance C. Visser,Heidi B. Kellihan,Isabelle Masseau,Elizabeth A. Rozanski,Cécile Clercx,Kurt J. Williams,Jonathan A Abbott,M. Borgarelli,Brian A. Scansen +9 more
TL;DR: Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions.
Biochemical Basis for the Hypercoagulable State Seen in Cushing Syndrome
TL;DR: In this paper, the authors used a dog model of Cushing syndrome to better define the biochemical basis for the hypercoagulable state seen in the disease seen in humans.
113
Mitotane (o, p‘‐DDD) Treatment of 200 Dogs with Pituitary‐Dependent Hyperadrenocorticism
TL;DR: Two hundred dogs with pituitary dependent hyperadrenocorticism were treated with mitotane at an initial daily dosage of 21 to 69 mg/kg for 5 to 14 days and exhibited one or more adverse effects during initial induction, including weakness, vomiting, anorexia, diarrhea, and ataxia.
104
ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
James W. Swann,Oliver A. Garden,Claire L. Fellman,Barbara Glanemann,Robert Goggs,Dana N. LeVine,Andrew J. Mackin,Nathaniel T. Whitley +7 more
TL;DR: A novel tool for evaluation of evidence quality was developed, using it to assess study design, diagnostic criteria, explanation of treatment regimens, and validity of statistical methods, which led to a set of clinical recommendations regarding treatment of IMHA in dogs.
99